Iptacopan significantly slowed kidney function decline over 24 months compared with placebo in adults with IgA nephropathy. The complement inhibitor was granted accelerated approved in 2024; continued ...
The brand has earned hundreds of glowing, five-star reviews for its range designed to help women feel 'steady and supported'.
Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology company $19 million financings to advance lead clinical candidate PTC-2105 for sarcopenia and age-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results